- Cancer-Related Ischemic Stroke Has a Distinct Blood mRNA Expression Profile. Stroke. 2019 Academic Article GET IT
Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma.
Times cited: 8
- Staging identifies non-CNS malignancies in a large cohort with newly diagnosed lymphomatous brain lesions. Leukemia and Lymphoma. 2019 Article GET IT
Ibrutinib unmasks critical role of bruton tyrosine kinase in primary CNS lymphoma.
Times cited: 68